Clinical trials
Active, not recruiting Neurofibroma, Plexiform trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| National Cancer Institute (NCI) | 3 |
| Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2 |
| Children's National Research Institute | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Novartis Pharmaceuticals | 1 |
| SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 1 |
| St. Justine's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurofibroma, Plexiform | 13 |
| Neurofibromatosis 1 | 11 |
| Neurofibroma | 3 |
| Brain Neoplasms | 2 |
| Glioma | 2 |
| Neuroblastoma | 2 |
| Astrocytoma | 1 |
| Central Nervous System Neoplasms | 1 |
| Ganglioglioma | 1 |
| Ganglioneuroma | 1 |
Trials
Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.